跳至主要内容
临床试验/NCT03487354
NCT03487354已完成2 期

Medical Abortion With Multiple vs Single Daily Dose of Misoprostol in First Trimester Miscarriage: A Randomized Clinical Trial.

Ain Shams University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
200
试验地点
1
主要终点
Complete miscarriage

研究概览

简要总结

Medical abortion using multiple vs single daily dose of misoprostol in first trimester miscarriage.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Maternal age more than 18 years old (age of legal consent).
  • Gestational age less than 13 weeks.
  • Hemoglobin >10 g/dL.
  • BMI between 25 kg/m2 and 35 kg/m
  • Missed abortion.
  • Living fetus with multiple congenital malformations incompatible with life.

排除标准

  • Maternal age less than 18 years old.
  • Gestational age more than 12 weeks.
  • Hemoglobin <10 g/dL.
  • Anencephaly.
  • Fibroid uterus.
  • BMI less than 25kg/m2 and more than 35kg/m
  • Coagulopathy.
  • History or evidence of adrenal pathology.
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or letrozole.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).

研究组 & 干预措施

Single daily dose

Active Comparator

干预措施: Misoprostol (Drug)

Multiple daily doses

Active Comparator

干预措施: Misoprostol (Drug)

结局指标

主要结局

Complete miscarriage

时间窗: one week

Assessed by trans-vaginal ultrasound where endometrial thickness less than 15 mm is considered complete miscarriage

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed S Sweed, MD

Principal Investigator

Ain Shams University

研究点 (1)

Loading locations...

相似试验

Medical Abortion With Single Daily Dose of... | 临床试验